0000899243-19-006156.txt : 20190305
0000899243-19-006156.hdr.sgml : 20190305
20190305173459
ACCESSION NUMBER: 0000899243-19-006156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KURIYEL RALF
CENTRAL INDEX KEY: 0001733143
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 19659837
MAIL ADDRESS:
STREET 1: 41 SEYON ST
STREET 2: BLDG 1, STE. 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-01
0
0000730272
REPLIGEN CORP
RGEN
0001733143
KURIYEL RALF
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
Senior VP, R&D
Common Stock
2019-03-01
4
A
0
4700
0.00
A
21043
D
Common Stock
2019-03-05
4
S
0
2240
58.53
D
18803
D
Represents shares awarded pursuant to Performance Share Units ("PSUs"). The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria related to the filing of the 2018 Annual Report on Form 10-K, which was filed on March 1, 2019. These PSUs vested on March 1, 2019.
Sale of 2,240 shares in the open market to cover tax liability resulting from the release of restricted stock units and PSUs.
$58.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.30 to $58.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2019-03-05